CTMX vs DNA
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 03, 2026
CTMX
DNA
Investment Advisor Scores
DNA
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CTMX | DNA | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 14.2045 | 0 | Tie |
| PEG Ratio | -1.8 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -92.4% | -48.5% | DNA |
| Earnings Growth | 60.6% | 0.0% | CTMX |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 46.3/100 | 35.0/100 | CTMX |
| Profit Margin | 0.0% | -219.6% | CTMX |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | EXTENDED | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CTMX
MarkdownPrice below a falling SMA50 (slope -7.9%), weak momentum, RSI 32
DNA
NeutralMixed signals - no dominant trend phase, RSI 75
Fundamentals Snapshot
| Metric | CTMX | DNA |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -5.4 | -4.3 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.9% | -0.5% |
| Gross Margin | 1.0% | 0.7% |
| Operating Margin | -16.8% | -2.8% |
| EPS | -0.55 | -5.19 |
| Dividend Yield | — | — |